One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment ...
A new study published in JAMA Network Open examines the relationship between the anatomical location of postcolonoscopy colorectal cancers (PCCRCs) and patient mortality outcomes within the Veterans ...
One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment ...
Immunotherapy wipes out some colorectal tumors without surgery, signaling a major shift toward less invasive treatment.
According to the American Cancer Society, colorectal cancer is the second leading cause of cancer death. Enrichment of regulatory T cells (T-regs) in solid cancers is generally associated with poor ...
RTID system reduces unnecessary temporary diverting ileostomy use in rectal cancer surgery without increasing anastomotic ...
A new study published in the journal of Frontiers in Nutrition showed that when compared to other surgical techniques, ...
Prognostic biomarkers in colorectal cancer encompass a diverse array of molecular, cellular and systemic indicators that predict patient outcomes, guide therapeutic decisions and illuminate underlying ...
Prognosis in colorectal cancer is determined by an interplay of anatomical, cellular and molecular variables. Tumour stage at diagnosis remains the strongest predictor of survival, but variation ...
TAS-102 plus bevacizumab in refractory metastatic colorectal cancer: A systematic review and meta-analysis of randomized trials with validation from prospective single-arm studies. This is an ASCO ...
Tumor-Targeted IL-12 (PDS01ADC) With Hepatic Artery Infusion Pump Therapy for Colorectal Liver Metastases: Interim Analysis of a Nonrandomized Phase II Trial Patients with mCRC exposed to FTD-TPI + ...
Treos Bio, a clinical-stage company developing off-the-shelf and personalized active cancer immunotherapies, today announced three abstracts on its proprietary Promiscuous EPItopes (PEPI) Technology ...